Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Structure (London, England : 1993)|April 11, 2008
Coarse-grained MD simulations of membrane protein-bilayer self-assemblyKathryn A Scott, Peter J Bond, Anthony Ivetac, et al.
Biochemistry|February 23, 2012
Cystic fibrosis transmembrane conductance regulator: a molecular model defines the architecture of the anion conduction path and locates a "bottleneck" in the poreYohei Norimatsu, Anthony Ivetac, Christopher Alexander, et al.
Biochemistry|September 17, 2009
Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the poreChristopher Alexander, Anthony Ivetac, Xuehong Liu, et al.
Chemical Biology & Drug Design|January 11, 2014
Discovery of novel inhibitors of HIV-1 reverse transcriptase through virtual screening of experimental and theoretical ensemblesAnthony Ivetac, Sara E Swift, Paul L Boyer, et al.
Biopolymers|June 22, 2010
Characterization of a clinical polymer-drug conjugate using multiscale modelingLili X Peng, Anthony Ivetac, Akshay S Chaudhari, et al.
Nature|July 22, 2014
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875Ankita Srivastava, Jason Yano, Yoshihiko Hirozane, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp<sup>3</sup> character and an exquisite selectivity profileSimone V Bigi-Botterill, Anthony Ivetac, Erica L Bradshaw, et al.
RSC Medicinal Chemistry|December 22, 2022
Fragment optimization and elaboration strategies - the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hitsChristopher R Smith, Svitlana Kulyk, Misbha Ud Din Ahmad, et al.
Nature Chemical Biology|April 3, 2012
A combinatorial TIR1/AFB-Aux/IAA co-receptor system for differential sensing of auxinLuz Irina A Calderón Villalobos, Sarah Lee, Cesar De Oliveira, et al.
Bioorganic & Medicinal Chemistry|August 4, 2022
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitorsChristopher R Smith, Ruth Aranda, James G Christensen, et al.
Pageof 3